Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5301–5350 of 18644
announced that it has approved the appointment of Peter Mintzberg to serve as Grayscale’s new Chief Executive Officer and the principal executive officer of the Company, and a member of the Board of Directors of Grayscale, effective August 15, 2024.
Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
the appointment of Peter Mintzberg to serve as Grayscale’s new Chief Executive Officer and the principal executive officer of the Company, and a member of the Board of Directors of Grayscale, effective August 15, 2024.
On May 20, 2024, Stephen E. Croskrey informed Danimer Scientific, Inc. (the “Company”) of his intention to retire from employment with the Company on or before December 31, 2024.
Jennifer Fulk and the Company have mutually agreed that Ms. Fulk will step down from her position as Chief Financial Officer, effective as of May 20, 2024.
Effective as of May 20, 2024, the Board has appointed Ian Harris as Chief Financial Officer to succeed Ms. Fulk.
Ms. White replaces Stan Little, who has served as the Company’s Chief Executive Officer since July 2023.
On May 14, 2024, the Company announced that Deanna White accepted an offer to become the Company’s Interim Chief Executive Officer and Chief Operating Officer effective May 15, 2024 (the “Effective Date”).
Upon Mr. Anderson’s retirement, Laura “Divot” Ekizian, who has served as President and Chief Relationship Officer for QCBT for the past four years, will assume the role of Chief Executive Officer of QCBT in addition to her current role as President of QCBT.
On May 18, 2024, Michael Dastoor, most recently Interim Chief Executive Officer and Chief Financial Officer of Jabil, was appointed Chief Executive Officer.
On May 18, 2024, Kenneth S. Wilson ceased to serve as Chief Executive Officer and Director of Jabil Inc. ("Jabil") following the completion of the previously announced internal investigation related to corporate policies.
Mr. Gregory B. Hebard, currently Jabil’s Senior Vice President, Treasurer, was appointed Executive Vice President and Chief Financial Officer on May 18, 2024.
On May 17, the Board of Directors (the “Board”) of Ispire Technology, Inc. (the “Company”) appointed James Patrick McCormick as the new Chief Financial Officer of the Company
On May 15, 2024, Chief Financial Officer Mr. Daniel Machock’s service to Aspire and the Company ended
On May 15, 2024, John Penver, the Chief Financial Officer of TSS, Inc. (the “Company”) tendered his resignation as the Company’s Chief Financial Officer, effective June 15, 2024.
appointed William Elder, the Company’s current General Counsel, Corporate Secretary and Acting Principal Financial Officer, to serve as the Company’s Chief Financial Officer, effective June 1, 2024.
Dr. Tanner’s employment with the Company will terminate effective May 31, 2024, and, effective June 1, 2024, Dr. Tanner will begin service as a consultant to the Company.
On May 16, 2024, the Board appointed Jeffrey R. Geygan, Chairman of the Board, as Interim Chief Executive Officer, effective immediately.
On May 13, 2024, Starlette B. Johnson, Interim Chief Executive Officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”) and member of the Company’s Board of Directors (the “Board”), resigned from her position as Interim Chief Executive Officer effective immediately.
On May 15, 2024, Jeffrey Church informed Imunon, Inc. (the “Company”) of his intent to retire from all positions with the Company
effective June 1, 2024, the Company appointed David Gaiero to serve as the Company’s new Chief Financial Officer
appointed Stanley Beckley, 42, currently the Company’s Interim Chief Financial Officer, to serve as the Company’s Chief Financial Officer (“CFO”) on a permanent basis.
On April 10, 2024, the Board of Directors (the “Board”) of Lakeland Industries, Inc. (“Lakeland” or the “Company”) appointed James M. Jenkins, our current Acting President and Chief Executive Officer and Executive Chairman, as President and Chief Executive Officer of the Company, effective June 1, 2024 (the “Effective Date”).
On May 20, 2024, Michael Preston notified AdvanSix Inc. (the “Company”) of his intention to retire from his position as Chief Financial Officer during the 2024 fiscal year.
Mr. Anthony Geisler resigned as Chief Executive Officer of the Company, effective May 13, 2024.
Ms. Brenda Morris has been appointed by the Company’s Board of Directors to serve as the Company’s Interim Chief Executive Officer.
On May 15, 2024, Robert (Bob) McCormick indicated his intent to retire as the President and Chief Executive Officer of Douglas Dynamics, Inc. (the “ Company ”), effective as of July 8, 2024 (the “ Retirement Date ”).
after which Mr. Janik will serve as elected by the Board as the Company’s Interim President and Chief Executive Officer
On May 14, 2024, James Kellogg, the Chief Financial Officer (“CFO”) of the Company, provided a letter of resignation as CFO of the Company, effective as of May 14, 2024.
Venkatesh Nathamuni has been appointed Executive Vice President and Chief Financial Officer of the Company, effective as of June 3, 2024
On May 11, 2024, Venk Nathamuni provided Cirrus Logic, Inc. (the “Company”) with notice of his intent to resign from his position as Chief Financial Officer effective May 24, 2024.
the Company’s Board of Directors appointed Ulf Habermann, the Company’s current Principal Accounting Officer, as interim Chief Financial Officer effective upon Mr. Nathamuni’s resignation and until a successor is appointed.
succeeding Damon Audia who has served in that role since September 2023. Mr. Audia will continue to serve in his role as Senior Vice President and Chief Financial Officer.
Effective on May 14, 2024, EMCORE Corporation (the “Company”) appointed Matthew Vargas as interim Principal Executive Officer.
Effective as of June 17, 2024, Austin Harbour, 43, will serve as the Chief Financial Officer of the Company.
Lance Turner, the Chief Financial Officer, will resign from the Company, effective June 17, 2024.
David Keffer, Corporate Vice President and Chief Financial Officer, will be retiring from the Company. Mr. Keffer will step down from his position on October 1, 2024, but will remain an employee of the Company until his retirement from the Company on February 21, 2025 to help facilitate an orderly transition.
The Company announced that Kenneth Crews was elected Corporate Vice President and Chief Financial Officer effective October 1, 2024.
Peter B. Crawford notified the Company of his intent to retire from his Managing Director and Chief Financial Officer position at the Company following a planned transition period with the effective date of his retirement to be determined in the future.
the Board of Directors of Aileron Therapeutics, Inc. (the “Company”) appointed Timothy M. Cunningham, a consultant at Danforth Advisors, LLC (“Danforth”), as interim chief financial officer, effective as of May 16, 2024.
Mr. Garner's departure from the Company on May 15, 2024.
On May 11, 2024, Daniel Tempesta notified Cerence Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company for personal reasons, effective as of May 17, 2024.
The Board of Directors of the Company has designated Stefan Ortmanns, President and Chief Executive Officer, as the Company’s principal financial officer, and Katherine Roman, Vice President and Corporate Controller, as the Company’s principal accounting officer, each on an interim basis and effective as of May 17, 2024.
On May 15, 2024, Leonardo Fernandes, the Chief Financial Officer of Spectaire Holdings Inc. (the “Company”) tendered his resignation as the Company’s Chief Financial Officer, including any positions held with any of the Company’s subsidiaries, effective May 15, 2024.
In connection with and effective as of Mr. Spierto’s appointment as Chief Accounting Officer, Briony R. Quinn, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, will no longer serve as principal accounting officer.
Effective May 9, 2024, Douglas Smith was given notice of his separation from The Arena Group Holdings, Inc (the “Company”).
On May 16, 2024, AEON Biopharma, Inc. (“AEON” or the “Company”) terminated the Consulting Agreement (the “Agreement”) between AEON and Peter Reynolds, which has resulted in his termination as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company effective as of May 17, 2024.
On May 16, 2024, our Board of Directors appointed Marc Forth, age 53, as our principal financial officer, effective as of May 17, 2024.
On May 11, 2024, as part of its succession plan for Mr. Ballschmiede’s role, the Company’s Board of Directors appointed Sharon R. Villaverde as CFO and CAO and the Company’s principal financial officer and principal accounting officer, effective May 13, 2024 (the “Effective Date”).
On February 12, 2024, Ronald A. Ballschmiede, Executive Vice President, Chief Financial Officer (“CFO”) and Chief Accounting Officer (“CAO”) and the Company’s principal financial officer and principal accounting officer of Sterling Infrastructure, Inc. (the “Company”), notified the Company of his plan to retire in 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.